Suspension of trading
PharmaSGP Holding SE Stock Deutsche Boerse AG
Stocks
PSG
DE000A2P4LJ5
Pharmaceuticals
|
Market Closed -
Deutsche Boerse AG
09:08:13 11/08/2025 +03
|
5-day change | 1st Jan Change | ||
| 28.80 EUR | +0.70% |
|
-.--% | - |
| 24/09/25 | PharmaSGP Holding SE Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| 11/09/25 | PharmaSGP Holding SE Reaffirms Earnings Guidance for the Financial Year 2025 | CI |
| 1 day | +0.70% |
| 3 years | 18 |  | 29.6 |
| 5 years | 18 | | 29.6 |
| 10 years | 14.8 | | 37.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Gerckens
CEO | Chief Executive Officer | 39 | 01/01/2025 |
Michael Rudolf
DFI | Director of Finance/CFO | 52 | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Clemens Fischer
CHM | Chairman | 51 | 04/03/2020 |
| Director/Board Member | 45 | 04/03/2020 | |
Axel Rebien
BRD | Director/Board Member | 55 | 01/06/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.70% | -.--% | - | - | 447M | |
| -0.65% | -2.93% | +47.70% | +86.17% | 994B | |
| -0.29% | -3.51% | +49.15% | +62.35% | 640B | |
| +0.83% | +0.26% | +17.76% | +72.25% | 454B | |
| -0.38% | -3.59% | +30.13% | +35.17% | 337B | |
| -0.09% | -13.54% | +13.34% | +24.95% | 261B | |
| -0.43% | -2.48% | -0.73% | +9.58% | 246B | |
| -1.34% | -13.70% | +36.53% | +44.96% | 204B | |
| -3.44% | -7.51% | -20.63% | -59.44% | 190B | |
| -0.75% | -4.82% | +25.46% | +87.14% | 178B | |
| Average | -0.58% | -5.76% | +22.08% | +40.35% | 389.42B | |
| Weighted average by Cap. | -0.51% | -4.42% | +30.96% | +54.95% |
Employees
98
Sector
Pharmaceuticals
- Stock Market
- Stocks
- PSG Stock
- PSG Stock
Select your edition
All financial news and data tailored to specific country editions
